Since our last feature on data exports in October 2020, we've seen significant developments including the EU's new draft standard contractual clauses, draft UK adequacy agreements and guidance on applying the Schrems II judgment. We also look at the impact of data export rules on clinical trial data, data exports from Asia, and data transfers in the context of M&A deals.